Skip to content

Walking Program With Pedometer on Quality of Life in COPD

The Effect of Walking Program With Pedometer on Quality-of-life Among Chronic Obstructive Pulmonary Disease Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05251623
Acronym
COPD
Enrollment
45
Registered
2022-02-23
Start date
2018-03-01
Completion date
2019-03-31
Last updated
2022-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, pedometer, physical activity, quality of life

Brief summary

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Detailed description

Patients with chronic obstructive pulmonary disease (COPD) are suffered from impaired pulmonary function and dyspnea which result to limited level of physical activity, and impaired quality of life. Exercise and regular physical activity have been proven to break the vicious circle. The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the pulmonary function was assessed by spiromtery test. The exercise capacity were assessed by six-minute walking test, the physical activity level was assessed by daily steps, The quality of life was assessed by COPD Assessment Test (CAT), and quality of life questionnaire (SF-12). .

Interventions

Subjects in PG walked to target steps daily with pedometer for 6 weeks

Sponsors

Chang Gung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. diagnosed with COPD 2. in a medically stable condition 3. able to walk unassisted 4. ≥ 40 years of age

Exclusion criteria

1. oxygen therapy, 2. hemodynamic instability, 3. signs/symptoms of acute infection 4. severe neurological, musculoskeletal, or cardiovascular conditions that affect walking

Design outcomes

Primary

MeasureTime frameDescription
tidal volumeweek 0the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.
Short-form 12 questionnaire (SF-12)week 0The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)
6 minute walking testweek 0walking distance
daily stepsweek0the number of total walking steps per day which is measured by pedometer.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026